Bacteriocins and their position in the next wave of conventional antibiotics

International Journal of Antimicrobial Agents

Volumn 46, Issue 5, 2015, Pages 494-501

  Cavera, Veronica L ^a   Arthur, Timothy D ^a   Kashtanov, Dimitri ^b   Chikindas, Michael L ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Antibiotic targets; Antimicrobial peptides; Bacteriocins; Future medicine; Synergy

Indexed keywords

ANTIBIOTIC AGENT; AUREOCIN A53; AUREOCIN A70; BAC GM17; BACTERIOCIN; CARBAPENEM DERIVATIVE; CAROCIN S2; CEPHALOSPORIN DERIVATIVE; CLOACIN DF13; COLICIN; DYSGALACTICIN; EXOTOXIN; GARVICIN A; GEOBACILIN I; GLYCOPEPTIDE; LACTICIN 481; LACTICIN Q; LACTOCOCCIN 972; LACTOCOCCIN A; LACTOCOCCIN B; MESENTERICIN Y105; MICROCIN B17; MONOBACTAM DERIVATIVE; NAI 107; NISIN; NUKACIN ISK 1; PEDIOCIN LIKE BACTERIOCIN; PENICILLIN DERIVATIVE; PROTEIN; SUBTILOSIN A; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIUM; COMMUNITY ECOLOGY; DRUG DELIVERY SYSTEM; HUMAN; MICROBIAL COMMUNITY; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; BACTERIAL INFECTIONS; DRUG DEVELOPMENT; TRENDS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIOCINS; DRUG DISCOVERY; HUMANS;

EID: 84947028153     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.07.011     Document Type: Review

References (98)

1. C.A. Michael, D. Dominey-Howes, and M. Labbate The antimicrobial resistance crisis: causes, consequences, and management Front Public Health 2 2014 145
2. O. Gillor, L.M. Nigro, and M.A. Riley Genetically engineered bacteriocins and their potential as the next generation of antimicrobials Curr Pharm Des 11 2005 1067 1075
3. M.C.A. Lages, K. Beilharz, D. Morales Angeles, J.-W. Veening, and D.-J. Scheffers The localization of key Bacillus subtilis penicillin binding proteins during cell growth is determined by substrate availability J Appl Microbiol 15 2013 3272 3281
4. P.D. Cotter, R.P. Ross, and C. Hill Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 11 2013 95 105
5. K. Bush, P. Courvalin, G. Dantas, J. Davies, B. Eisenstein, P. Huovinen, and et al. Tackling antibiotic resistance Nat Rev Microbiol 9 2011 894 896
6. R.F. Inglis, B. Bayramoglu, O. Gillor, and M. Ackermann The role of bacteriocins as selfish genetic elements Biol Lett 9 2013 20121173
7. L. Micenková, B. Taudová, J. Bosák, L. Mikalová, S. Littnerová, M. Vrba, and et al. Bacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains BMC Microbiol 14 2014 109
8. P.M. O'Connor, E.F. O'Shea, C.M. Guinane, O. O'Sullivan, P.D. Cotter, R.P. Ross, and et al. Nisin H is a new nisin variant produced by the gut-derived strain Streptococcus hyointestinalis DPC6484 Appl Environ Microbiol 81 2015 3953 3960
9. H. Majeed, A. Lampert, L. Ghazaryan, and O. Gillor The weak shall inherit: bacteriocin-mediated interactions in bacterial populations PLOS ONE 8 2013 e63837
10. H. Yamashita, H. Tomita, T. Inoue, and Y. Ike Genetic organization and mode of action of a novel bacteriocin, bacteriocin 51: determinant of VanA-type vancomycin-resistant Enterococcus faecium Antimicrob Agents Chemother 55 2011 4352 4360
11. R.W. Phelan, M. Barret, P.D. Cotter, P.M. O'Connor, R. Chen, J.P. Morrissey, and et al. Subtilomycin: a new lantibiotic from Bacillus subtilis strain MMA7 isolated from the marine sponge Haliclona simulans Mar Drugs 11 2013 1878 1898
12. Y. Cui, C. Zhang, Y. Wang, J. Shi, L. Zhang, Z. Ding, and et al. Class IIa bacteriocins: diversity and new developments Int J Mol Sci 13 2012 16668 16707
13. M.A. Riley Bacteriocins, biology, ecology, and evolution M. Schaechter, Encyclopedia of microbiology 3rd ed. 2009 Elsevier 32 44
14. T.R. Klaenhammer Genetics of bacteriocins produced by lactic acid bacteria FEMS Microbiol Rev 12 1993 39 85
15. I.F. Nes, D.B. Diep, and Y. Ike Enterococcal bacteriocins and antimicrobial proteins that contribute to niche control M.S. Gilmore, D.B. Clewell, Y. Ike, N. Shankar, Enterococci: from commensals to leading causes of drug resistant infection 2014 Massachusetts Eye and Ear Infirmary Boston, MA http://www.ncbi.nlm.nih.gov/books/NBK190428/?report=reader [accessed 09.07.15]
16. A. Pons, F. Delalande, M. Duarte, S. Benoit, I. Lanneluc, S. Sablé, and et al. Genetic analysis and complete primary structure of microcin L Antimicrob Agents Chemother 48 2004 505 513
17. F. Collin, R.E. Thompson, K.A. Jolliffe, R.J. Payne, and A. Maxwell Fragments of the bacterial toxin microcin B17 as gyrase poisons PLOS ONE 8 2013 e61459
18. L.E. Lancaster, A. Savelsbergh, C. Kleanthous, W. Wintermeyer, and M.V. Rodnina Colicin E3 cleavage of 16S rRNA impairs decoding and accelerates tRNA translocation on Escherichia coli ribosomes Mol Microbiol 69 2008 390 401
19. K. Schaller, and M. Nomura Colicin E2 is DNA endonuclease Proc Natl Acad Sci U S A 73 1976 3989 3993
20. T. Ogawa, S. Inoue, S. Yajima, M. Hidaka, and H. Masaki Sequence-specific recognition of colicin E5, a tRNA-targeting ribonuclease Nucleic Acids Res 34 2006 6065 6073
21. T.M. Karpiński, and A.K. Szkaradkiewicz Characteristic of bacteriocines and their application Pol J Microbiol 62 2013 223 235
22. F. Bourdichon, S. Casaregola, C. Farrokh, J.C. Frisvad, M.L. Gerds, W.P. Hammes, and et al. Food fermentations: microorganisms with technological beneficial use Int J Food Microbiol 154 2012 87 97
23. J.-D. Cha, J.-H. Lee, K.M. Choi, S.-M. Choi, and J.H. Park Synergistic effect between cryptotanshinone and antibiotics against clinic methicillin and vancomycin-resistant Staphylococcus aureus Evid Based Complement Alternat Med 2014 2014 450572
24. M.R. Gillings Evolutionary consequences of antibiotic use for the resistome, mobilome, and microbial pangenome Front Microbiol 4 2013 1 10
25. N. Garg, T.J. Oman, T.-S. Andrew Wang, C.V.G. De Gonzalo, S. Walker, and W.A. van der Donk Mode of action and structure-activity relationship studies of geobacillin I J Antibiot (Tokyo) 67 2014 133 136
26. D. Leitsch, A.G. Burgess, L.A. Dunn, K.G. Krauer, K. Tan, M. Duchêne, and et al. Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia J Antimicrob Chemother 66 2011 1756 1765
27. L.M.T. Dicks, T.D.J. Heunis, D.A. van Staden, A. Brand, K. Sutyak Noll, and M.L. Chikindas Medical and personal care applications of bacteriocins produced by lactic acid bacteria D. Drider, S. Rebuffat, Prokaryotic antimicrobial peptides: from genes to applications 2011 Springer New York, NY 391 421
28. L.A. Draper, P.D. Cotter, C. Hill, and R.P. Ross The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria BMC Microbiol 13 2013 212
29. A. Penesyan, M. Gillings, and I. Paulsen Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities Molecules 20 2015 5286 5298
30. K. Lewis Platforms for antibiotic discovery Nat Rev Drug Discov 12 2013 371 387
31. H. Majeed, O. Gillor, B. Kerr, and M.A. Riley Competitive interactions in Escherichia coli populations: the role of bacteriocins ISME J 5 2011 71 81
32. G.O. Gutkind, J. Di Conza, P. Power, and M. Radice β-Lactamase-mediated resistance: a biochemical, epidemiological and genetic overview Curr Pharm Des 19 2013 164 208
33. K.D. Modi, M.L. Chikindas, and T.J. Montville Sensitivity of nisin-resistant Listeria monocytogenes to heat and the synergistic action of heat and nisin Lett Appl Microbiol 30 2000 249 253
34. A.S. Mazzotta, and T.J. Montville Nisin induces changes in membrane fatty acid composition of Listeria monocytogenes nisin-resistant strains at 10°C and 30°C J Appl Microbiol 82 1997 32 38
35. A.S. Nayar, T.J. Dougherty, K.E. Ferguson, B.A. Granger, L. McWilliams, C. Stacey, and et al. Novel antibacterial targets and compounds revealed by a high-throughput cell wall reporter assay J Bacteriol 197 2015 1726 1734
36. S. Van Teeffelen, S. Wang, L. Furchtgott, K.C. Huang, N.S. Wingreen, J.W. Shaevitz, and et al. The bacterial actin MreB rotates, and rotation depends on cell-wall assembly Proc Natl Acad Sci U S A 108 2011 15822 15827
37. T.K. Lee, C. Tropini, J. Hsin, S.M. Desmarais, T.S. Ursell, E. Gong, and et al. A dynamically assembled cell wall synthesis machinery buffers cell growth Proc Natl Acad Sci U S A 111 2014 4554 4559
38. J.F. Allard, and A.D. Rutenberg Steady-state helices of the actin homolog MreB inside bacteria: dynamics without motors Phys Rev E76 2007 031916
39. M. Prado-Acosta, S.M. Ruzal, M.C. Allievi, M.M. Palomino, and C. Sanchez Rivas Synergistic effects of the Lactobacillus acidophilus surface layer and nisin on bacterial growth Appl Environ Microbiol 76 2010 974 977
40. I.M. Gut, S.R. Blanke, and W.A. van der Donk Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin ACS Chem Biol 6 2011 744 752
41. Q. Wang, X. Zeng, S. Wang, C. Hou, F. Yang, X. Ma, and et al. The bacteriocin sublancin attenuates intestinal injury in young mice infected with Staphylococcus aureus Anat Rec (Hoboken) 297 2014 1454 1461
42. M. Badaoui Najjar, D. Kashtanov, and M.L. Chikindas ε-Poly-l-lysine and nisin A act synergistically against Gram-positive food-borne pathogens Bacillus cereus and Listeria monocytogenes Lett Appl Microbiol 45 2007 13 18
43. K. Okuda, T. Zendo, S. Sugimoto, T. Iwase, A. Tajima, S. Yamada, and et al. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm Antimicrob Agents Chemother 57 2013 5572 5579
44. M. Kawada-Matsuo, Y. Yoshida, T. Zendo, J. Nagao, Y. Oogai, Y. Nakamura, and et al. Three distinct two-component systems are involved in resistance to the class I bacteriocins, Nukacin ISK-1 and nisin A, in Staphylococcus aureus PLOS ONE 8 2013 e69455
45. M.R. Islam, M. Nishie, J. Nagao, T. Zendo, S. Keller, J. Nakayama, and et al. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic J Am Chem Soc 134 2012 3687 3690
46. M. Sosio, G. Gallo, R. Pozzi, S. Serina, P. Monciardini, A. Bera, and et al. Draft genome sequence of the Microbispora sp. strain ATCC-PTA-5024, producing the lantibiotic NAI-1075024 Genome Announc 2 2014 pii:e01198-13
47. D. Münch, A. Müller, T. Schneider, B. Kohl, M. Wenzel, J.E. Bandow, and et al. The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions J Biol Chem 289 2014 12063 12076
48. C. Chatterjee, G.C. Patton, L. Cooper, M. Paul, and W.A. van der Donk Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase Chem Biol 13 2006 1109 1117
49. C. Chatterjee, L.M. Miller, Y.L. Leung, L. Xie, M. Yi, N.L. Kelleher, and et al. Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production J Am Chem Soc 127 2005 15332 15333
50. G. Mouloud, H. Daoud, J. Bassem, I. Laribi Atef, and B. Hani New bacteriocin from Bacillus clausii strain GM17: purification, characterization, and biological activity Appl Biochem Biotechnol 171 2013 2186 2200
51. V. Ahmad, A. Kamal, K. Ahmad, and M.S. Khan Protease characteristics of bacteriocin producing lysinibacilli, isolated from fruits and vegetable waste Bioinformation 10 2014 13 18
52. W.S. Champney Bacterial ribosomal subunit synthesis: a novel antibiotic target Curr Drug Targets Infect Disord 1 2001 19 36
53. S. Shakil, R. Khan, R. Zarrilli, and A.U. Khan Aminoglycosides versus bacteria - a description of the action, resistance mechanism, and nosocomial battleground J Biomed Sci 15 2008 5 14
54. C.L. Ng, K. Lang, N.A.G. Meenan, A. Sharma, A.C. Kelley, and et al. Structural basis for ribosomal 16S rRNA cleavage by the cytotoxic domain of colicin E3 Nat Struct Mol Biol 17 2013 1241 1246
55. A. Akutsu, H. Masaki, and T. Ohta Molecular structure and immunity specificity of colicin E6, an evolutionary intermediate between E-group colicins and cloacin DF13 J Bacteriol 171 1989 6430 6436
56. M. Toba, H. Masaki, T. Ohta, and E8 Colicin a DNase which indicates an evolutionary relationship between colicins E2 and E3 J Bacteriol 170 1988 3237 3242
57. D.C. Walker, T. Georgiou, A.J. Pommer, D. Walker, G.R. Moore, C. Kleanthous, and et al. Mutagenic scan of the H-N-H motif of colicin E9: implications for the mechanistic enzymology of colicins, homing enzymes and apoptotic endonucleases Nucleic Acids Res 30 2002 3225 3234
58. L. Mora, and M. de Zamaroczy In vivo processing of DNase colicins E2 and E7 is required for their import into the cytoplasm of target cells PLOS ONE 9 2014 e96549
59. F. Garza-Sánchez, J.G. Gin, and C.S. Hayes Amino acid starvation and colicin D treatment induce A-site mRNA cleavage in Escherichia coli J Mol Biol 378 2009 505 519
60. M. Graille, L. Mora, R.H. Buckingham, H. van Tilbeurgh, and M. de Zamaroczy Structural inhibition of the colicin D tRNase by the tRNA-mimicking immunity protein EMBO J 23 2004 1474 1482
61. Y.-C. Chan, J.-L. Wu, H.-P. Wu, K.-C. Tzeng, and D.-Y. Chuang Cloning, purification, and functional characterization of carocin S2, a ribonuclease bacteriocin produced by Pectobacterium carotovorum BMC Microbiol 11 2011 99
62. M.B.C. Fontana, M.D.C. Freire De Bastos, and A. Brandelli Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters Curr Microbiol 52 2006 350 353
63. U. Pag, C. Heidrich, G. Bierbaum, and H.G. Sahl Molecular analysis of expression of the lantibiotic Pep5 immunity phenotype Appl Environ Microbiol 65 1999 591 598
64. A. Sharma, and S. Srivastava Anti-Candida activity of two-peptide bacteriocins, plantaricins (Pln E/F and J/K) and their mode of action Fungal Biol 118 2014 264 275
65. P.M. Swe, N.C.K. Heng, G.M. Cook, J.R. Tagg, and R.W. Jack Identification of DysI, the immunity factor of the streptococcal bacteriocin dysgalacticin Appl Environ Microbiol 76 2010 7885 7889
66. D.B. Diep, M. Skaugen, Z. Salehian, H. Holo, and I.F. Nes Common mechanisms of target cell recognition and immunity for class II bacteriocins Proc Natl Acad Sci U S A 104 2007 2384 2389
67. K. Dalet, Y. Cenatiempo, P. Cossart, and Y.A. Héchard σ(54)-dependent PTS permease of the mannose family is responsible for sensitivity of Listeria monocytogenes to mesentericin Y105 Microbiology 147 2001 3263 3269
68. D.J.A. Netz, D.C. de Freire Bastos, and H.-G. Sahl Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus Appl Environ Microbiol 68 2002 5274 5280
69. M.L.V. Coelho, J. dos Santos Nascimento, P.C. Fagundes, D.J. Madureira, S.S. de Oliveira, M.A.V. de Paiva Brito, and et al. Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis Res Microbiol 158 2007 625 630
70. M.C.F. Bastos, H. Ceotto, M.L. Coelho, and J.S. Nascimento Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications Curr Pharm Biotechnol 10 2009 38 61
71. M. Li, F. Yoneyama, N. Toshimitsu, T. Zendo, J. Nakayama, and K. Sonomoto Lethal hydroxyl radical accumulation by a lactococcal bacteriocin, lacticin Q Antimicrob Agents Chemother 57 2013 3897 3902
72. F. Yoneyama, Y. Imura, K. Ohno, T. Zendo, J. Nakayama, K. Matsuzaki, and et al. Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q Antimicrob Agents Chemother 53 2009 3211 3217
73. F. Yoneyama, K. Ohno, Y. Imura, M. Li, T. Zendo, J. Nakayama, and et al. Lacticin Q-mediated selective toxicity depending on physicochemical features of membrane components Antimicrob Agents Chemother 55 2011 2446 2450
74. K. Fujita, S. Ichimasa, T. Zendo, S. Koga, F. Yoneyama, J. Nakayama, and et al. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of Gram-positive bacteria Appl Environ Microbiol 73 2007 2871 2877
75. M.J. Sánchez-Barrena, M. Martínez-Ripoll, A. Gálvez, E. Valdivia, M. Maqueda, V. Cruz, and et al. Structure of bacteriocin AS-48: from soluble state to membrane bound state J Mol Biol 334 2003 541 549
76. M.J. Grande Burgos, R.P. Pulido, M. Del Carmen López Aguayo, A. Gálvez, and R. Lucas The cyclic antibacterial peptide enterocin AS-48: isolation, mode of action, and possible food applications Int J Mol Sci 15 2014 22706 22727
77. X. Gong, L.A. Martin-Visscher, D. Nahirney, J.C. Vederas, and M. Duszyk The circular bacteriocin, carnocyclin A, forms anion-selective channels in lipid bilayers Biochim Biophys Acta 1788 2009 1797 1803
78. R.T. Fernley, P. Iliades, and I. Macreadie A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors Anal Biochem 360 2007 227 234
79. A. Maldonado-Barragán, N. Cárdenas, B. Martínez, J.L. Ruiz-Barba, J.F. Fernández-Garayzábal, J.M. Rodríguez, and et al. Garvicin A, a novel class IId bacteriocin from Lactococcus garvieae that inhibits septum formation in L. garvieae strains Appl Environ Microbiol 79 2013 4336 4346
80. B. Martínez, A. Rodríguez, and J.E. Suárez Lactococcin 972, a bacteriocin that inhibits septum formation in lactococci Microbiology 146 2000 949 955
81. S.S. Justice, J. García-Lara, and L.I. Rothfield Cell division inhibitors SulA and MinC/MinD block septum formation at different steps in the assembly of the Escherichia coli division machinery Mol Microbiol 37 2000 410 423
82. T. Den Blaauwen, J.M. Andreu, and O. Monasterio Bacterial cell division proteins as antibiotic targets Bioorg Chem 55 2014 27 38
83. A.P. Singh, V. Prabha, and P. Rishi Value addition in the efficacy of conventional antibiotics by nisin against Salmonella PLOS ONE 8 2013 e76844
84. R. Rink, J. Wierenga, A. Kuipers, L.D. Kluskens, A.J.M. Driessen, O.P. Kuipers, and et al. Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation Appl Environ Microbiol 73 2007 5809 5816
85. A. Plat, L.D. Kluskens, A. Kuipers, R. Rink, and G.N. Moll Requirements of the engineered leader peptide of nisin for inducing modification, export, and cleavage Appl Environ Microbiol 77 2011 604 611
86. B. Healy, D. Field, P.M. O'Connor, C. Hill, P.D. Cotter, and R.P. Ross Intensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives PLOS ONE 8 2013 e79563
87. A. Campion, P.G. Casey, D. Field, P.D. Cotter, C. Hill, and R.P. Ross In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice BMC Microbiol 13 2013 23
88. P.D. Cotter, L.A. Draper, E.M. Lawton, O. McAuliffe, C. Hill, and R.P. Ross Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147 Appl Environ Microbiol 72 2006 4492 4496
89. S.K. Tiwari, K. Sutyak Noll, V.L. Cavera, and M.L. Chikindas Improved antimicrobial activities of synthetic-hybrid bacteriocins designed from enterocin E50-52 and pediocin PA-1 Appl Environ Microbiol 81 2015 1661 1667
90. T.D. Arthur, V.L. Cavera, and M.L. Chikindas On bacteriocin delivery systems and potential applications Future Microbiol 9 2014 235 248
91. V.L. Cavera, A. Volski, and M.L. Chikindas The natural antimicrobial subtilosin A synergizes with lauramide arginine ethyl ester (LAE), ε-poly-l-lysine (polylysine), clindamycin phosphate and metronidazole, against the vaginal pathogen Gardnerella vaginalis Probiotics Antimicrob Proteins 7 2015 164 171
92. T. Amrouche, K. Sutyak Noll, Y. Wang, Q. Huang, and M.L. Chikindas Antibacterial activity of subtilosin alone and combined with curcumin, poly-lysine and zinc lactate against Listeria monocytogenes strains Probiotics Antimicrob Proteins 2 2010 250 257
93. K.S. Noll, M.N. Prichard, A. Khaykin, P.J. Sinko, and M.L. Chikindas The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-l-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli Antimicrob Agents Chemother 56 2012 1756 1761
94. K.I. Wolska, K. Grzes, and K. Anna Synergy between novel antimicrobials and conventional antibiotics or bacteriocins Pol J Microbiol 61 2012 95 104
95. W. Brumfitt, M.R.J. Salton, and J.M.T. Hamilton-Miller Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci J Antimicrob Chemother 50 2002 731 734
96. O. Lobos, A. Padilla, and C. Padilla In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains Arch Oral Biol 54 2009 230 234
97. A.P. Singh, S. Preet, and P. Rishi Nisin/β-lactam adjunct therapy against Salmonella enterica serovar Typhimurium: a mechanistic approach J Antimicrob Chemother 69 2014 1877 1887
98. M.C. Rea, D. Alemayehu, P.G. Casey, P.M. O'Connor, P.G. Lawlor, M. Walsh, and et al. Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract Microbiology 160 2014 439 445